BioTime Stock Quote
$0.92 -$0.07 0.0%
BATS BZX Real Time Price as of August 9, 2019, 4:00 p.m. EDT View Interactive BTX Charts

BioTime Inc. is engaged in the business of developing blood plasma volume expanders and related products and stem cell related products and technology for diagnostic therapeutic and research use.

News & Analysis: BioTime


Market Moves


3 Reasons Behind Geron's Rebound

Let’s take a look at three reasons Geron bounced back more than 200% in 2013, and how its industry peers -- Celgene, Novartis, and Incyte -- have been affected.

The Worst of 2012: BioTime

Continuing our countdown of the very worst healthcare stocks of 2012, BioTime comes in at No. 20.

The Bearish Case for BioTime

A light R&D budget, a technology that may not be commercially viable, and a stock prone to promotion make one investor skeptical of BioTime's prospects.

Interactive Chart